Literature DB >> 22683349

Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway.

Tharine Dal-Cim1, Simone Molz, Javier Egea, Esther Parada, Alejandro Romero, Josiane Budni, Maria D Martín de Saavedra, Laura del Barrio, Carla I Tasca, Manuela G López.   

Abstract

Mitochondrial perturbation and oxidative stress are key factors in neuronal vulnerability in several neurodegenerative diseases or during brain ischemia. Here we have investigated the protective mechanism of action of guanosine, the guanine nucleoside, in a human neuroblastoma cell line, SH-SY5Y, subjected to mitochondrial oxidative stress. Blockade of mitochondrial complexes I and V with rotenone plus oligomycin (Rot/oligo) caused a significant decrease in cell viability and an increase in ROS production. Guanosine that the protective effect of guanosine incubated concomitantly with Rot/oligo abolished Rot/oligo-induced cell death and ROS production in a concentration dependent manner; maximum protection was achieved at the concentration of 1mM. The cytoprotective effect afforded by guanosine was abolished by adenosine A(1) or A(2A) receptor antagonists (DPCPX or ZM241385, respectively), or by a large (big) conductance Ca(2+)-activated K(+) channel (BK) blocker (charybdotoxin). Evaluation of signaling pathways showed that the protective effect of guanosine was not abolished by a MEK inhibitor (PD98059), by a p38(MAPK) inhibitor (SB203580), or by a PKC inhibitor (cheleritrine). However, when blocking the PI3K/Akt pathway with LY294002, the neuroprotective effect of guanosine was abolished. Guanosine increased Akt and p-Ser-9-GSK-3β phosphorylation confirming this pathway plays a key role in guanosine's neuroprotective effect. Guanosine induced the antioxidant enzyme heme oxygenase-1 (HO-1) expression. The protective effects of guanosine were prevented by heme oxygenase-1 inhibitor, SnPP. Moreover, bilirubin, an antioxidant and physiologic product of HO-1, is protective against mitochondrial oxidative stress. In conclusion, our results show that guanosine can afford protection against mitochondrial oxidative stress by a signaling pathway that implicates PI3K/Akt/GSK-3β proteins and induction of the antioxidant enzyme HO-1.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22683349     DOI: 10.1016/j.neuint.2012.05.021

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  45 in total

1.  A Novel Compound YS-5-23 Exhibits Neuroprotective Effect by Reducing β-Site Amyloid Precursor Protein Cleaving Enzyme 1's Expression and H2O2-Induced Cytotoxicity in SH-SY5Y Cells.

Authors:  Chen Cheng; Nan Zheng; Deyang Sun; Weishuo Fang; Lingling Zheng; Weihong Song; Jian Huang
Journal:  Neurochem Res       Date:  2020-06-18       Impact factor: 3.996

2.  Neuroprotective Effects of Guanosine Administration on In Vivo Cortical Focal Ischemia in Female and Male Wistar Rats.

Authors:  Luciele Varaschini Teixeira; Roberto Farina Almeida; Francieli Rohden; Leo Anderson Meira Martins; Poli Mara Spritzer; Diogo Onofre Gomes de Souza
Journal:  Neurochem Res       Date:  2018-05-31       Impact factor: 3.996

3.  Intranasal Administration of GDNF Protects Against Neural Apoptosis in a Rat Model of Parkinson's Disease Through PI3K/Akt/GSK3β Pathway.

Authors:  Peijian Yue; Lin Gao; Xuejing Wang; Xuebing Ding; Junfang Teng
Journal:  Neurochem Res       Date:  2017-02-28       Impact factor: 3.996

4.  Neurotoxin mechanisms and processes relevant to Parkinson's disease: an update.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2015-01-29       Impact factor: 3.911

5.  Duloxetine Protects Human Neuroblastoma Cells from Oxidative Stress-Induced Cell Death Through Akt/Nrf-2/HO-1 Pathway.

Authors:  Daiane Fátima Engel; Jade de Oliveira; Vicente Lieberknecht; Ana Lucia Severo Rodrigues; Andreza Fabro de Bem; Nelson Horácio Gabilan
Journal:  Neurochem Res       Date:  2017-11-13       Impact factor: 3.996

6.  Anti-aging effects of guanosine in glial cells.

Authors:  Débora Guerini Souza; Bruna Bellaver; Larissa Daniele Bobermin; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Purinergic Signal       Date:  2016-09-01       Impact factor: 3.765

7.  Oxidative stress and antioxidant therapy in traumatic spinal cord injuries.

Authors:  Ovidiu Horea Bedreag; Alexandru Florin Rogobete; Mirela Sărăndan; Alina Cradigati; Marius Păpurică; Oana Maria Roşu; Corina Maria Dumbuleu; Dorel Săndesc
Journal:  Rom J Anaesth Intensive Care       Date:  2014-10

Review 8.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

9.  Guanosine and GMP increase the number of granular cerebellar neurons in culture: dependence on adenosine A2A and ionotropic glutamate receptors.

Authors:  Helena Decker; Tetsade C B Piermartiri; Cláudia B Nedel; Luciana F Romão; Sheila S Francisco; Tharine Dal-Cim; Carina R Boeck; Vivaldo Moura-Neto; Carla I Tasca
Journal:  Purinergic Signal       Date:  2019-09-02       Impact factor: 3.765

10.  Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems.

Authors:  Roberto Farina Almeida; Daniel Diniz Comasseto; Denise Barbosa Ramos; Gisele Hansel; Eduardo R Zimmer; Samanta Oliveira Loureiro; Marcelo Ganzella; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.